{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:33:38Z","timestamp":1776893618147,"version":"3.51.2"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brazilian Journal of Otorhinolaryngology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bjorl.2018.05.014","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T15:07:08Z","timestamp":1531840028000},"page":"636-641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antineutrophil cytoplasmic antibodies in patients treated with methimazole: a prospective Brazilian study"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7183-5505","authenticated-orcid":false,"given":"Gabriela Costa","family":"Andrade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8825-757X","authenticated-orcid":false,"given":"Flavia Coimbra Pontes","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0916-3490","authenticated-orcid":false,"given":"Gabriela Franco","family":"Mour\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5190-382X","authenticated-orcid":false,"given":"Pedro Weslley","family":"Rosario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-1886","authenticated-orcid":false,"given":"Maria Regina","family":"Calsolari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjorl.2018.05.014_bib0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/S0004-27302013000300006","article-title":"The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism","volume":"57","author":"Maia","year":"2013","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0115","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0120","first-page":"477","article-title":"Long-term continuous methimazole or radioiodine treatment for hyperthyroidism","volume":"15","author":"Azizi","year":"2012","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0125","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/thy.2015.0195","article-title":"Outcomes in Relapsed Graves\u2019 disease patients following radioiodine or prolonged low dose of methimazole treatment","volume":"25","author":"Villagelin","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0130","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/EJE-16-0938","article-title":"Management of endocrine disease: arguments for the prolonged use of antithyroid drugs in children with Graves\u2019 disease","volume":"177","author":"L\u00e9ger","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0135","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/thy.2014.0603","article-title":"Antineutrophil cytoplasmic antibody-positive small-vessel vasculitis associated with antithyroid drug therapy: how significant is the clinical problem?","volume":"25","author":"Balavoine","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1309\/WAEPADW0K4LPUHFN","volume":"120","author":"Savige","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.reuma.2014.02.010","article-title":"Antineutrophil cytoplasm antibody: positivity and clinical correlation","volume":"11","author":"Mart\u00ednez T\u00e9llez","year":"2015","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0150","first-page":"4270","article-title":"High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves\u2019disease treated with propylthiouracil","volume":"85","author":"Sato","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0155","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/thy.2000.10.595","article-title":"Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves\u2019 disease","volume":"10","author":"Sera","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1081\/ERC-120037729","article-title":"The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic autoantibodies (ANCA) in Chinese patients with hyperthyroidism","volume":"30","author":"Gao","year":"2004","journal-title":"Endocr Res"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0165","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1507\/endocrj.49.329","article-title":"Prevalence of serum anti-myeloperoxydase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves\u2019 disease treated with propylthiouracil and thiamazole","volume":"49","author":"Wada","year":"2002","journal-title":"Endocr J"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0170","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/eje.0.1420587","article-title":"Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication","volume":"142","author":"Gunton","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0175","first-page":"274","article-title":"Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves\u2019 disease treated with propylthiouracil or methimazole in Taiwan","volume":"103","author":"Huang","year":"2004","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/art.20927","article-title":"Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term follow up study","volume":"53","author":"Slot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0185","first-page":"446","article-title":"Relationship between methimazole and antineutrophil cytoplasmic antibody-positive vasculitis","volume":"46","author":"Chen","year":"2008","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0190","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2265.2004.02029.x","article-title":"Propylthiouracil and carbimazole associated\u2013antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves\u2019 disease","volume":"60","author":"Harper","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0195","first-page":"412","article-title":"Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease","volume":"50","author":"Cabral","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0200","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s10620-009-0998-7","article-title":"Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease","volume":"55","author":"Nisihara","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0205","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1210\/jc.2008-2700","article-title":"Clinical characteristics of myeloperoxydase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs","volume":"94","author":"Noh","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bjorl.2018.05.014_bib0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1742-1241.2007.01485.x","article-title":"Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment","volume":"64","author":"Yazisiz","year":"2010","journal-title":"Int J Clin Pract"}],"container-title":["Brazilian Journal of Otorhinolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869418304294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869418304294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:35:19Z","timestamp":1761723319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1808869418304294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1808869418304294"],"URL":"https:\/\/doi.org\/10.1016\/j.bjorl.2018.05.014","relation":{},"ISSN":["1808-8694"],"issn-type":[{"value":"1808-8694","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antineutrophil cytoplasmic antibodies in patients treated with methimazole: a prospective Brazilian study","name":"articletitle","label":"Article Title"},{"value":"Brazilian Journal of Otorhinolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjorl.2018.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Associa\u00e7\u00e3o Brasileira de Otorrinolaringologia e Cirurgia C\u00e9rvico-Facial. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}